- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 487/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/04
Total number of patents in this class: 20795
10-year publication summary
|
1437
|
1449
|
1484
|
1577
|
1648
|
1778
|
1652
|
1720
|
1761
|
477
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
535 |
| F. Hoffmann-La Roche AG | 7958 |
379 |
| Janssen Pharmaceutica N.V. | 3839 |
343 |
| Novartis AG | 11238 |
333 |
| Merck Sharp & Dohme LLC | 3689 |
280 |
| Merck Patent GmbH | 5909 |
269 |
| Hoffmann-La Roche Inc. | 3060 |
265 |
| Gilead Sciences, Inc. | 1879 |
250 |
| Incyte Corporation | 918 |
239 |
| Boehringer Ingelheim International GmbH | 4629 |
229 |
| Takeda Pharmaceutical Company Limited | 2961 |
194 |
| Genentech, Inc. | 3742 |
192 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
190 |
| Pfizer Inc. | 3322 |
185 |
| AstraZeneca AB | 3042 |
160 |
| Incyte Holdings Corporation | 609 |
155 |
| Abbvie Inc. | 1808 |
117 |
| Merck Sharp & Dohme Corp. | 2247 |
114 |
| LG Chem, Ltd. | 17205 |
111 |
| Bayer Pharma AG | 1096 |
111 |
| Other owners | 16144 |